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In vertebrates, Toll-like receptors (TLRs) re-
spond to an array of pathogen-expressed mol-
ecules by initiating a series of intracellular 
signaling events that activate innate immunity 
and, thus, play a crucial role in the response 
to infection (Akira et al., 2006; Leulier and 
Lemaitre, 2008). Although this system is capa-
ble of providing a fast and vigorous response, 
it has to be kept under tight control to avoid 
hyperresponsiveness that would be detrimental 
to  the  host  by  initiating  such  pathologies  as 
sepsis, chronic inflammation, and autoimmu-
nity (Nathan, 2002). Key upstream processes in 
TLR signal transduction include MyD88 and 
MAL adaptor binding and phosphorylation of 
the IRAK family kinases. Subsequent ubiqui-
tination of the TRAF6 complex leads to activa-
tion of NF-B and mitogen-activated protein 
kinase (MAPK) proteins, which ultimately in-
duce the transcription of inflammatory genes 
(Doyle and O’Neill, 2006; Kawai and Akira, 
2006). The remaining innate and adaptive im-
mune responses are highly dependent on the 
time course and composition of this early in-
flammatory milieu (Hoebe et al., 2004). Thus, a 
detailed understanding of the initial events in 
TLR signaling is critical to predicting the entire 
nature of a response to pathogen invasion as well 
as identifying the safest and most effective sub-
strates for targeted antiinflammatory therapies.
IRAK family kinases are centrally positioned 
in the TLR signaling cascade, and, as such, they 
have been implicated as key positive and neg-
ative  inflammatory  regulators  (Janssens  and 
Beyaert, 2003). Two family members, IRAK-1 
and IRAK-4 have been shown to promote 
inflammation (Cao et al., 1996; Thomas et al., 
1999; Swantek et al., 2000; Li et al., 2002; 
Suzuki et al., 2002), whereas IRAK-M has a 
demonstrated inhibitory effect (Kobayashi et al., 
2002).  Recently  reported  gene  targeting  of 
IRAK-2  firmly  established  its  importance  in 
sustaining high levels of inflammation at late 
time points (Kawagoe et al., 2008; Wan et al., 
2009). However, the exact role of IRAK-2 
in TLR-mediated signaling remains less clear 
because other studies imply its involvement in 
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In a phenotypic screen of the wild-derived mouse strain MOLF/Ei, we describe an earlier 
and more potent toll-like receptor (TLR)–mediated induction of IL-6 transcription com-
pared with the classical inbred strain C57BL/6J. The phenotype correlated with increased 
activity of the IB kinase axis as well as p38, but not extracellular signal-regulated kinase 
or c-Jun N-terminal kinase, mitogen-activated protein kinase (MAPK) phosphorylation. The 
trait was mapped to the Why1 locus, which contains Irak2, a gene previously implicated as 
sustaining the late phase of TLR responses. In the MOLF/Ei TLR signaling network, IRAK-2 
promotes early nuclear factor B (NF-B) activity and is essential for the activation of p38 
MAPK. We identify a deletion in the MOLF/Ei promoter of the inhibitory Irak2c gene, 
leading to an increased ratio of pro- to antiinflammatory IRAK-2 isoforms. These findings 
demonstrate that IRAK-2 is an essential component of the early TLR response in MOLF/Ei 
mice and show a distinct pathway of p38 and NF-B activation in this model organism. In 
addition, they demonstrate that studies in evolutionarily divergent model organisms are 
essential to complete dissection of signal transduction pathways.
© 2009 Conner et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.jem.org/misc/terms.shtml). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/
licenses/by-nc-sa/3.0/).
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with opposite effects on the trait. Our previous study identi-
fied a novel antiinflammatory role for IRAK-1BP1 (IRAK-1 
binding protein or SIMPL) that is encoded by Why2 (Conner 
et al., 2008). In this paper, we provide evidence that IRAK-2 
is the product of Why1. The effect is caused by a 10-bp dele-
tion in the promoter area of the inhibitory isoform IRAK-2C, 
thus resulting in relatively higher levels of expression of the 
proinflammatory isoform of IRAK-2 in MOLF/Ei as com-
pared with C57BL/6. These findings extend our knowledge 
of the role and importance of IRAK-2 in TLR-mediated sig-
naling. Furthermore, they emphasize the versatile nature of 
the innate immune system, which is able to undergo substan-
tial changes in the utilization of core signaling factors even 
within the course of evolution of a single species.
RESULTS
Hyperresponsiveness to TLR/IL-1R activation in MOLF/Ei mice
Macrophages from the wild-derived mouse strain MOLF/Ei 
induce transcription of the proinflammatory cytokine IL-6 
faster and in higher quantities upon TLR stimulation when 
compared with the classical inbred strain C57BL/6J (Conner 
et al., 2008). In an attempt to gain mechanistic insight into 
the molecular events underlying this hyperresponsive pheno-
type, we examined the transcriptional response of additional 
cytokine genes early after stimulation with the TLR2 agonist 
LTA. Although MOLF/Ei macrophages displayed an in-
creased amount of IL-6 transcript, two other proinflamma-
tory genes, TNF- and IL-12p40, were induced to similar 
levels in MOLF/Ei and C57BL/6J cells (Fig. 1 A).
Individual inflammatory stimuli, such as TNFR, IL-1R, 
and TLR agonists, use a combination of shared and stimulus-
specific downstream mediators to induce cytokine gene tran-
scription (Verstrepen et al., 2008). To gain insight into which 
signaling components are hyperresponsive in MOLF/Ei 
mice, we tested mouse embryonic fibroblasts (MEFs) from 
MOLF/Ei and C57BL/6J strains for their response to IL-1 
and TNF- stimulation. Whereas MOLF/Ei MEFs displayed 
increased IL-6 production relative to C57BL/6J in response 
to  IL-1,  equivalent  levels  of  IL-6  were  produced  upon 
TNF- stimulation (Fig. 1 B). These findings suggest that the 
factor promoting increased IL-6 production in MOLF/Ei 
cells is shared between the MyD88-dependent TLR and 
IL-1R pathways but is not common to the TNFR pathway.
Complete induction of responsive genes upon TLR stim-
ulation requires a combination of downstream signaling 
events, including transcriptional activation through the NF-B 
family factors, chromatin remodeling, and activity of the 
MAPK  proteins  p38,  extracellular  signal-regulated  kinase 
(ERK), and c-Jun N-terminal kinase (JNK; Kawai and Akira, 
2006). Individual inflammatory genes exhibit different re-
quirements for each of these activities, a feature which aids in 
conferring specificity to immune responses (Saccani et al., 
2002; Park et al., 2005; Sanjabi et al., 2005; Foster et al., 2007). 
To assess the activation status of upstream molecular media-
tors in MOLF/Ei and C57BL/6J macrophages, Western blot 
analysis was performed. Examination of phosphorylation 
early  signaling  events  (Muzio  et  al.,  1997;  Keating  et  al., 
2007). Further elucidation of IRAK-2’s role in inflammatory 
signaling is critical to complete our understanding of the role 
of all members of the IRAK family. Experimentation is com-
plicated by the fact that there are four isoforms of IRAK-2 in 
mice, with at least one of them, IRAK-2C, being inhibitory, 
whereas there is only one human IRAK-2 isoform (Hardy 
and O’Neill, 2004). Thus, the model system in which the 
function of IRAK-2 is interrogated may be a critical determi-
nant of the conclusions that are reached.
Classical inbred strains of mice have been instrumental in 
the genetic analysis of innate immunity. Observations on the 
molecular nature of the immune response in laboratory mice 
are highly reproducible because of their genetic homogeneity. 
Many, though not all, of these features have been shown to 
recapitulate parallel human processes, an expected outcome 
given the high level of homology between the genomes 
(Waterston et al., 2002; Mestas and Hughes, 2004). However, 
because most of the classical inbred mouse strains descend 
from a relatively restricted number of founder animals largely 
within the Mus mus domesticus subspecies (Frazer et al., 2007; 
Yang et al., 2007), their genetic diversity is limited, thereby 
restricting their utility for phenotypic screening. It is therefore 
not surprising that the genetics of innate immunity has been 
increasingly studied by other means, such as genome-wide 
ENU mutagenesis, which has resulted in numerous remark-
able discoveries of gene functions (Beutler et al., 2006).
Wild-derived mice, which diverged from the common 
ancestor of classical strains more than one million years ago, 
provide an additional reservoir of genetic diversity, which, 
unlike that resulting from laboratory mutagenesis, has arisen 
in an evolutionary context (Guenet and Bonhomme, 2003). 
As a result of their early divergence, many of the wild-
derived strains have large genomic regions originating from 
the subspecies M. m. musculus and M. m. castaneus (Frazer 
et al., 2007; Yang et al., 2007). When compared with com-
monly used inbred strains, they exhibit polymorphisms every 
100–200 bp (Ideraabdullah et al., 2004). This genetic diver-
sity is a rich substrate for experimental interrogation. The 
likelihood of phenotypic variation in these strains is increased 
compared with that observed between classical strains. Fur-
thermore, novel phenotypes that are revealed likely have 
important biological consequences because they have been 
selected naturally over the course of subspeciation. Wild-
derived mice are an emerging, though still largely unexplored, 
model for the identification and study of novel immunologi-
cal genes. Their usefulness as genetic models is exemplified 
by studies exploring response to pathogen infections as well 
as lethality mediated by TNF (Urosevic et al., 1999; Staelens 
et al., 2002; Sancho-Shimizu and Malo, 2006).
To identify novel factors that regulate TLR signaling, we 
initiated a genetic screen in wild-derived and classical inbred 
mice and identified a novel dominant phenotype of hyperre-
sponse to LPS, peptidoglycan, and lipoteichoic acid (LTA) in 
several wild-derived strains. We have focused on two loci, 
termed Why1 and Why2 (wild-derived hyperresponse 1 and 2), JEM VOL. 206, July 6, 2009 
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status for all three MAPK family members revealed that p38, 
but not ERK or JNK, was activated faster and at higher levels 
in MOLF/Ei cells (Fig. 1 C). Furthermore, assessment of the 
Figure 1.  Hyperactivation of cytokines and intracellular mediators in TLR2-stimulated MOLF/Ei macrophages. (A) Peritoneal macrophages 
from C57BL/6J and MOLF/Ei mice were stimulated with 2 µg/ml LTA for the indicated times. Cytokine mRNA was quantified by real-time PCR. Data repre-
sent mean ± range from duplicate wells. One of at least three representative experiments is shown. (B) MEFs were prepared from MOLF/Ei and C57BL/6J 
mice and stimulated with 100 ng/ml human IL-1 or TNF- for the indicated times. IL-6 mRNA was quantified using real-time PCR. Data are shown as 
mean ± range from duplicate wells, representative of two independent experiments. (C–E) BMDMs from each strain were stimulated with 2 µg/ml LTA for 
the indicated times. Cytoplasmic protein lysates were analyzed by Western blot analysis for MAPK (C) and NF-B (D) pathway activity or IRAK-1 degrada-
tion (E). Data are representative of three (C and D) or two (E) independent experiments.
IB kinase (IKK) axis of TLR signaling was performed by 
observing  the  direct  phosphorylation  of  the  IB  family 
member p105 as well as the IKK-dependent process of 1618 CENTRAL ROLE FOR IRAK-2 IN THE MOLF/Ei TLR RESPONSE | Conner et al.
proteasome-mediated  degradation  of  IB  and  IB. 
Each of these processes was enhanced in MOLF/Ei mac-
rophages relative to C57BL/6J (Fig. 1 D). Thus, MOLF/Ei 
mice exhibit a specific enhancement in p38 and IKK activity 
after TLR2 stimulation.
We next asked if more receptor proximal and regulatory 
signaling events also displayed increased activity in the MOLF/Ei 
TLR response. Stimulus-induced degradation of IRAK-1   
is a well characterized outcome of IL-1R/TLR signaling 
(Yamin and Miller, 1997), which is believed to be an impor-
tant inhibitory event (Siedlar et al., 2004). An examination of 
IRAK-1 protein concentration after TLR2 stimulation re-
vealed that MOLF/Ei macrophages did not degrade IRAK-1 
more quickly than C57BL/6J but, rather, exhibited a slightly 
more prolonged IRAK-1 half-life (Fig. 1 E). Together, these 
findings  imply  that  the  hyperresponsiveness  in  MOLF/Ei 
TLR signaling is biased toward specific proinflammatory out-
comes, with regulatory functions such as IRAK-1 protein 
degradation showing equivalent or decreased activity.
Genetic mapping of high IL-6 production in MOLF/Ei
We next sought to elucidate the genetic basis for the differ-
ence in TLR-stimulated MOLF/Ei and C57BL/6J macro-
phages. We previously reported that genome-wide linkage 
analysis in a panel of  N2(C57BL/6Jx(C57BL/6JxMOLF/Ei)) 
mice identified two loci associated with LTA-stimulated IL-6 
secretion (Conner et al., 2008). The MOLF/Ei allele at one 
of these loci, Why2, was negatively associated with IL-6 pro-
duction, which was the result of a cis-acting gene regulatory 
element allowing TLR-inducible expression of the negative 
regulator IRAK-1BP1. We therefore focused on the Why1 
locus, a 21-Mb region on chromosome 6 between markers 
D6MIT36 and TNFRSF1a. Using secreted IL-6 protein 6 h 
after activation with LTA, a codominant mode of inheritance 
was observed as indicated by the intermediate phenotype of 
F1(B6xMOLF) mice (Fig. 2 A). Evaluation of 82 N2 back-
cross  mice  by  this  assay  revealed  a  significantly  increased 
amount of IL-6 secretion associated with a copy of the MOLF 
Why1 allele (Fig. 2 B), indicating that a factor promoting 
TLR-stimulated IL-6 production in MOLF/Ei mice is con-
tained within this genomic interval.
We assessed IL-6 protein secretion after only 6 h of LTA 
stimulation in an effort to maximize the effect of the early 
signaling differences depicted in Fig. 1, C and D. However, 
the possibility remained that late-acting effects, such as dif-
ferences in protein translation, stability, or secretion, were 
playing a significant role in the phenotypic outcome. We 
therefore assessed IL-6 transcript 1 h after stimulation to 
confirm that the underlying polymorphism at Why1 was 
functioning within the initial pathway leading to TLR-induced 
gene transcription. Increased IL-6 messenger RNA (mRNA) 
accumulation 1 h after stimulation was significantly associated 
with the MOLF Why1 allele (Fig. 2 C). Thus, the Why1 
locus interacts with TLR pathways within the first hour 
after activation.
Figure 2.  TLR2-stimulated IL-6 production is associated with the 
Why1 locus. (A) Codominant inheritance of IL-6 protein secretion. Peri-
toneal macrophages from parental strains and F1(C57BL/6JxMOLF/Ei) 
hybrid mice were plated and stimulated for 6 h with the indicated  
concentrations of LTA. IL-6 secretion was measured by ELISA. Results  
are ± SEM from triplicate wells, representative of three independent  
experiments. (B) Peritoneal macrophages from 82 N2 (C57BL/6Jx(C57BL/
6JxMOLF/Ei)) mice were plated and stimulated with 2 µg/ml LTA as in A. 
Mean IL-6 production from triplicate wells is plotted for each mouse, 
grouped by genotype at D6MIT328, a marker near the peak of the Why1 
locus. (C) Peritoneal macrophages from 50 independent N2 backcross 
mice were stimulated for 1 h with 2 µg/ml LTA. IL-6 mRNA was quantified 
by real time PCR. Mean mRNA production from two wells is plotted, 
grouped by genotype at D6MIT328. P-values were calculated in  
B and C using a two-tailed Student’s t test.JEM VOL. 206, July 6, 2009 
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with wild-type C57BL/6J (Fig. 3, A and B). In contrast, a 
much smaller effect was observed for TNF- transcription. 
This effect was not TLR2 specific, as macrophages from con-
genic mice were hyper-responsive to TLR3, TLR4, TLR9, 
and TLR7 stimulation as well (Fig. 3 C).
We next addressed the upstream signaling effects of the 
Why1 locus isolated on a C57BL/6J background. In contrast 
to pure MOLF/Ei cells, Why1 congenic macrophages did not 
display an increase in p38 activation. A slightly more rapid 
degradation of IB was observed in peritoneal macrophages, 
which is consistent with increased IKK activity (Fig. 3 D). The 
observed rate of IB degradation by Western blot analysis 
was only incrementally increased in peritoneal macrophages 
and was not observed in BM-derived macrophages (BMDMs; 
Fig. 3 D and not depicted). We reasoned that this may be 
caused by the low sensitivity of Western blot analysis in detect-
ing slight differences in NF-B pathway activity. To assess 
more subtle effects on NF-B in Why1 congenic macrophages, 
we examined TLR-induced transcription of CCL3 (MIP-1). 
The CCL3 promoter has been shown to be predominantly 
dependent on NF-B activity and to contain fewer additional 
elements than the IL-6 promoter (Grove and Plumb, 1993). 
We observed increased CCL3 transcription in TLR2-stimulated 
Why1 congenic macrophages relative to those from wild-type 
C57BL/6J mice (Fig. 3 E), which is consistent with increased 
NF-B activity in these cells. We conclude that MOLF/Ei 
background alleles, in addition to Why1, are important in con-
ferring the robust levels of phenotypic differences in p38 and 
NF-B activity, which is detectable by Western blot analysis in 
Fig. 1 (C and D). However, the Why1 locus itself is sufficient 
to partially recapitulate the hyperresponsiveness, as shown by 
increased cytokine transcription and the small but detectable 
effects on IB degradation.
Essential role of IRAK-2 in the MOLF/Ei early TLR response
Of the genes located within the Why1 interval (Table S1), Irak2 
emerged as a leading candidate to underlie the detected linkage 
because of the IRAK family’s known role in TLR signal trans-
duction. Previous studies have demonstrated that this gene is not 
required for early activation of NF-B and early cytokine tran-
scription on a classical inbred background (Kawagoe et al., 2008; 
Wan et al., 2009). Consistent with these findings, IRAK-2 
knockdown in BMDMs using two effective short hairpin RNA 
In both association studies (Fig. 2, B and C), all mice that 
were homozygous for the C57BL/6J allele of Why1 were 
low producers of IL-6, indicating that the MOLF/Ei Why1 
allele is necessary for N2 mice to generate a heightened re-
sponse. In contrast, mice with a heterozygous genotype for 
Why1 exhibited a wide range of secreted IL-6. These data 
indicate that heterozygosity for Why1 alone is not sufficient 
to confer high levels of IL-6 but probably acts in combination 
with additional MOLF/Ei alleles.
To confirm that the Why1 locus is a critical heritable de-
terminant of IL-6 production in TLR-stimulated macro-
phages, we assessed its inheritance through five generations 
of mice chosen for serial backcrossing to C57BL/6J on a phe-
notypic basis. At each generation, peritoneal macrophages 
were isolated from each mouse using a nonlethal method and 
high-responding mice were identified for continued back-
crossing. Mice producing high levels of IL-6 in each genera-
tion were significantly more likely to carry a MOLF allele of 
the Why1 locus (Table I) as determined by a transmission 
disequilibrium test (Beebe et al., 1997). Together, these data 
demonstrate that the Why1 genomic interval is required for 
the MOLF/Ei TLR hyperresponsive phenotype.
Genetic background complements the effects of Why1
The detected genetic linkage to the Why1 locus suggests that 
the MOLF/Ei allele of Why1 is uniquely capable of mediating 
the hyperresponsive phenotype depicted in Fig. 1. However, 
the extent to which this locus depends upon the activity of 
other MOLF/Ei genes is not clear. Indeed, haplotype group-
ing  of  TLR2-mediated  IL-6  production  revealed  that  N2 
backcross mice homozygous for the C57BL/6J allele of Why1 
were universally low responders, whereas a wide distribution 
of responses was observed for mice containing a copy of the 
MOLF/Ei allele (Fig. 2, B and C). These data imply that the 
MOLF/Ei allele of Why1 is necessary but not sufficient for   
the earlier and more robust activation of TLR signaling.
To test the effect of the Why1 locus on TLR signaling in 
the absence of other MOLF/Ei genes, we generated a con-
genic strain, which contained a MOLF/Ei haplotype for the 
entire Why1 interval on a C57BL/6J background. TLR2-
stimulated IL-6 transcription and protein secretion were in-
creased in C57BL/6J-Why1MOLF/MOLF macrophages, although 
not to the same extent as in pure MOLF/Ei mice, compared 
Table I.  Transmission disequilibrium test of the Why1 locus in high IL-6–secreting mice through the N6 generation
Total mice High mice used for breeding 2 P-value
Why1 genotype
Generation Hom Het Total
N2 41 1 11 12
N3 67 0 7 7
N4 28 0 6 6
N5 32 0 3 3
N6 32 1 6 7
Total 200 2 33 35 12.86 0.00031620 CENTRAL ROLE FOR IRAK-2 IN THE MOLF/Ei TLR RESPONSE | Conner et al.
IRAK-2 is required for IL-6 production in MOLF/Ei but not 
C57BL/6J macrophages early after TLR stimulation.
To assess the mechanism by which IRAK-2 promotes early 
transcription of IL-6 in MOLF/Ei peritoneal macrophages, we 
examined the effect of IRAK-2 knockdown on IKK and 
(shRNA) targeting constructs had no effect on the relatively 
small amount of IL-6 produced by C57BL/6J mice. In contrast, 
knockdown of IRAK-2 in MOLF/Ei BMDMs severely atten-
uated TLR2-induced IL-6 mRNA and protein accumulation 
4 and 6 h after stimulation, respectively (Fig. 4, A–C). Thus, 
Figure 3.  Increased IL-6 production in C57BL/6J-Why1MOLF/MOLF congenic mice. (A and B) Peritoneal macrophages were isolated from wild-type 
and Why1 congenic mice and stimulated with 2 µg/ml LTA. IL-6 or TNF mRNA was analyzed by real-time PCR at the indicated times (A) and IL-6 protein 
secretion was analyzed by ELISA 6 h after stimulation (B). (C) Cells were stimulated for 2 h with 100 ng/ml LPS, 2 µg/ml LTA, 200 nM CpG, 100 µM 
Loxoribine, or 25 µg/ml poly(I:C), and IL-6 mRNA was analyzed by real-time PCR. Data shown as mean ± range of duplicate wells (A and C) or ± SEM of 
triplicate wells (B). (D) Cells from wild-type and Why1 congenic mice were stimulated with 2 µg/ml LTA for the indicated times and protein was extracted 
for Western blot analysis of p38 activation and IB degradation. Total p38 served as a loading control. (E) Peritoneal macrophages from the indicated 
strains were stimulated with 2 µg/ml LTA for the indicated times and CCL3 mRNA was measured by real-time PCR analysis. Error bars indicate SEM. All 
experiments are representative of two to three independent trials.JEM VOL. 206, July 6, 2009 
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Figure 4.  IRAK-2 is required for early TLR2 responses in MOLF/Ei but not C57BL/6J macrophages. (A–C) C57BL/6J and MOLF/Ei BMDMs were 
infected with lentiviral constructs containing either control or one of three IRAK-2–targeting shRNA sequences. (A) To assess knockdown efficiency, mRNA 
was harvested and cDNA was amplified with IRAK-2 or GAPDH-specific PCR primers. (B and C) Cells were stimulated with 2 µg/ml LTA and IL-6 was quanti-
fied at 4 h using RT-PCR, with error bars indicating SEM (B), or at 6 h using ELISA, with error bars indicating SEM (C). n.d., not detected. Data are represen-
tative of three independent experiments. (D and E) MOLF/Ei BMDMs were infected with control or IRAK-2–targeting construct number two and stimulated 
with 2 µg/ml LTA (D) or under hypertonic NaCl conditions (E) for the indicated times. MAPK and NF-B pathway signaling events were assessed using the 
indicated Western blot analyses. Total p38 and ERK serve as loading controls. Data are representative of at least two independent experiments.1622 CENTRAL ROLE FOR IRAK-2 IN THE MOLF/Ei TLR RESPONSE | Conner et al.
knockdown cells (Fig. 4 D), suggesting that in MOLF/Ei mice, 
IRAK-2 affects the IKK–NF-B axis above the level of IKK 
activation. We next examined the phosphorylation status of the 
MAPK proteins JNK, p38, and ERK. LTA-induced p38 activ-
ity was severely impaired by IRAK2 knockdown (Fig. 4 D). 
This effect was specific for IRAK-dependent pathways, as 
osmotically stressed macrophages activated p38 to equal levels 
MAPK activation status by Western blot analysis (Fig. 4 D). 
IRAK-2 knockdown impaired the IKK-dependent processes of 
IB degradation and p105 phosphorylation. To more directly 
assay the activation status of IKK, we measured TLR2-induced 
phosphorylation of the IKK- subunit, which is the major IKK 
component targeted by TLR signal transduction (Bonizzi and 
Karin, 2004). IKK- phosphorylation was impaired in IRAK-2 
Figure 5.  The effect of IRAK-2 knockdown in macrophages is allele specific. (A and B) BMDMs from C57BL/6J and C57BL/6J-Why1MOLF/MOLF mice 
were transduced with control or an IRAK-2–targeting shRNA construct. Cells were stimulated with 2 µg/ml LTA for 6 h followed by IL-6 ELISA analysis  
(A) or for the indicated times followed by IL-6 mRNA quantification by real-time PCR (B). Real-time PCR data are shown as the fold change (in Ct values) 
observed in IRAK-2 shRNA treated relative to control-treated cells. Data shown as mean ± SEM from triplicate wells (A) or ± range from duplicate wells 
(B), representative of two independent experiments. (C) Peritoneal macrophages from 14 Why1 homozygous or 9 heterozygous N2 backcross mice were 
plated and infected with control or IRAK-2–targeting shRNA constructs. 3 d after infection, cells were stimulated with 2 µg/ml LTA and IL-6 protein secre-
tion was measured by ELISA. Mean values of three wells for each mouse are plotted. P-values were calculated using a paired Student’s t test analysis.JEM VOL. 206, July 6, 2009 
ARTICLE
1623
in control and IRAK-2–targeted knockdown cells (Fig. 4 E). 
In comparison with p38 status, JNK was more marginally af-
fected and a slightly delayed onset of ERK phosphorylation 
was observed (Fig. 4 D). Thus, IRAK-2 knockdown in 
MOLF/Ei macrophages affects IKK activity, as well as all three 
MAPKs with the largest effect on p38.
The data depicted in Fig. 4 imply that IRAK-2 occupies 
a  critical  position  in  MOLF/Ei  TLR  signal  transduction. 
However, they do not address the question of whether allelic 
variation in IRAK-2 itself is responsible for the increased 
dependence  on  this  gene  or,  alternatively,  whether  other 
MOLF/Ei gene products function to promote hyperrespon-
siveness through a requisite interaction with IRAK-2. To 
address this question, we assayed the effect of IRAK-2 
shRNA knockdown in C57BL/6J-Why1 congenic macro-
phages, which contain the MOLF/Ei allele of Irak2 on a >98% 
C57BL/6J background. Why1 congenic BMDMs transduced 
with a control shRNA hairpin construct secreted an increased 
amount of IL-6 protein relative to C57BL/6J BMDMs 6 h 
after LTA stimulation. In contrast, IL-6 accumulation was 
similar between cells from both strains that were transduced 
with an IRAK-2–targeting hairpin (Fig. 5 A). We next exam-
ined the effect of IRAK2 knockdown on IL-6 transcription 
at various time points after TLR2 activation. The largest dif-
ference between strains in the response to IRAK-2 knock-
down was at the earliest time points tested, whereas by later 
times both strains showed a similar decrease in IL-6 mRNA 
levels. Surprisingly, IRAK-2 knockdown was associated with 
increased IL-6 accumulation in C57BL/6J cells at 30 and 60 
min after LTA stimulation, whereas a notable decrease was 
occurring in Why1 congenic macrophages at this time (Fig. 5 B). 
These data demonstrate that the MOLF/Ei allele of IRAK-2 
is particularly important for early TLR activity and suggest 
that the C57BL/6J allele may have a net inhibitory effect on 
IL-6 production at these time points.
Because we originally identified the Why1 locus through 
meiotic recombination events in N2 (C57BL/6Jx[C57BL/
6JxMOLF/Ei]) mice (Fig. 2, B and C), we hypothesized that 
genetically assorted progeny inheriting the MOLF/Ei Irak2 
allele would demonstrate increased sensitivity to knockdown 
compared with mice homozygous for the C57BL/6J allele. 
To test this hypothesis, we lentivirally infected peritoneal 
macrophages from a small panel of N2 backcross mice with 
IRAK-2–targeting shRNA construct 2, which showed the 
greatest efficiency of knockdown in BMDMs (Fig. 4 A).   
Although peritoneal macrophages are terminally differentiated 
and nondividing, we have observed up to 30% infection effi-
ciency with lentiviral constructs in these cells (Fig. S1). Con-
sistent with an increased dependence for IRAK-2 in mice 
inheriting a MOLF/Ei Why1 allele, Why1 heterozygotes, but 
not C57BL/6J homozygotes, produced significantly less IL-6 
when  expressing  an  IRAK-2  targeting  shRNA  compared 
with a nonhomologous control construct (Fig. 5 C). Thus, 
Irak2 is directly involved in the linkage of the trait to Why1.
Differential expression of IRAK-2 isoforms in MOLF/Ei  
and C57BL/6J mice
Sequence analysis of the IRAK-2 open reading frame revealed 
seven  nonsynonymous  mutations  between  MOLF/Ei  and 
C57BL/6J. Four of these mutations were also present in two 
Figure 6.  Ectopic expression of MOLF/Ei or C57BL/6J IRAK-2 isoforms results in similar effects on TLR2 activity. RAW264.7 macrophages 
were transduced with a lentiviral construct encoding the MOLF/Ei or C57BL/6J alleles of IRAK-2A (A) or IRAK-2C (B). Cells were stimulated for the indi-
cated times with 2 µg/ml LTA. Total levels of IRAK-2 in unstimulated cells as well as IL-6 and TNF mRNA accumulation were assessed by real-time PCR. 
Data are depicted as mean ± range of duplicate wells, representative of three independent experiments.1624 CENTRAL ROLE FOR IRAK-2 IN THE MOLF/Ei TLR RESPONSE | Conner et al.
ined  the  allelic  bias  of  mRNA  transcripts  produced  in 
F1(C57BL/6JxMOLF/Ei) macrophages. Allelic gene expres-
sion analysis based on a C→T polymorphism revealed a larger 
proportion of C57BL/6J allelic transcript in F1 cells (Fig. 8 A). 
This difference was amplified upon TLR stimulation, which 
is consistent with previous studies demonstrating that IRAK-2C 
is under the transcriptional control of inducible regulatory 
elements (Hardy and O’Neill, 2004).
We then proceeded to sequence the 4-kb intronic region, 
which contains the IRAK-2C promoter. Sequence compari-
son revealed two prime candidate mutations: an A→G point 
mutation in a GATA transcription factor consensus binding site 
and an 11-bp deletion in a region including a CACC SP1/KLF 
binding site (Philipsen and Suske, 1999). These mutations were 
also shared by two other wild-derived strains, Czech/Ei and 
MSM/Ms (Fig. 8 B), which are also hyperresponsive to TLR 
activation (Conner et al., 2008). To assess the effect of each 
mutant sequence on transcription factor binding, we conducted 
electromobility shift analysis (EMSA). The C57BL/6J, but not 
the MOLF/Ei, GATA element was bound by protein from a 
nuclear lysate prepared from the RAW264.7 macrophage cell 
line (Fig. 8 C). The CACC element was also capable of bind-
ing factors in macrophage nuclei, as the C57BL/6J oligonucle-
otide, but not the contiguous MOLF/Ei or a C57BL/6J version 
with mutations in place of the deleted region, was shifted by 
incubation with RAW264.7 nuclear extract (Fig. 8 D).
Finally, we examined the functional consequence of these 
mutations on gene expression in a macrophage cell line. Fusion 
of the luciferase gene to the promoter region containing the 
GATA site, as well as an NF-B element present in both 
strains, revealed a difference of approximately one to twofold 
between the MOLF/Ei and C57BL/6J sequences. Introduc-
tion of the CACC element–containing sequence, however, re-
sulted in a difference of 10–30-fold between strains (Fig. 8 E). 
Thus, although the GATA binding site alone may be responsi-
ble for a small fraction of the expression difference, the CACC 
site is required for the major increase in C57BL/6J IRAK-2C 
transcription relative to MOLF/Ei.
DISCUSSION
This study demonstrates the ability of an unbiased phenotypic 
screen in evolutionarily diverse mouse subspecies to refine our 
model of immune signaling pathways. Although the genetic di-
versity of these mouse strains has been appreciated previously, it 
has also limited their use in forward genetic analyses because of 
the often polygenic nature underlying observed traits. In addi-
tion, high levels of polymorphism in these mice, as compared 
with classical inbred strains, have made it difficult to establish a 
causative link between a candidate-gene and a phenotype. In 
our mapping of Why1, we were able to overcome these prob-
lems by performing knockdown of the candidate gene directly 
on a panel of backcross mice and showing an allele-specific 
effect of silencing (Fig. 5 C). This method, which was previ-
ously applied in describing the product of the Why2 locus, 
IRAK-1BP1 (Conner et al., 2008), greatly facilitated our ability 
to assess gene candidates in the context of genetic assortment.
other wild-derived strains with similar TLR-responsive phe-
notypes (Fig. S2). The Irak2 gene consists of four isoforms, of 
which two, IRAK-2C and IRAK-2D, are believed to nega-
tively regulate inflammatory signaling (Hardy and O’Neill, 
2004). We examined the potential contribution of the amino 
acid differences between strains by expressing IRAK-2A or 
IRAK-2C in the macrophage cell line RAW264.7. Consis-
tent with previous findings (Hardy and O’Neill, 2004), 
IRAK-2A from both strains potently increased TLR-mediated 
transcription of IL-6, whereas IRAK-2C had an inhibitory 
effect. However, no functional differences were detected 
between the alleles of either isoform (Fig. 6, A and B). There-
fore, we conclude that polymorphisms in the amino acid 
sequence of MOLF/Ei and C57BL/6J IRAK-2 do not un-
derlie the observed phenotype.
Gene expression polymorphisms are a common determi-
nant of quantitative traits (Schadt et al., 2005). We therefore 
performed real-time PCR analysis to examine the mRNA lev-
els of IRAK-2 isoforms in MOLF/Ei and C57BL/6J macro-
phages. We focused specifically on IRAK-2A as well as 
IRAK-2C, because the former is believed to be the major gene 
product of Irak2 and the latter is the only isoform that origi-
nates from a unique promoter within the third intron (Hardy 
and O’Neill, 2004). IRAK-2C expression demonstrated the 
largest difference between strains, with C57BL/6J expressing 
5–10-fold higher levels of this antiinflammatory mediator in 
both BMDMs and peritoneal macrophages (Fig. 7, A and B). 
To assess IRAK-2 transcriptional regulation by cis-acting ele-
ments in the absence of trans-acting differences, we compared 
C57BL/6J and C57BL/6J-Why1MOLF/MOLF peritoneal macro-
phages. Why1 congenic mice expressed higher levels of total 
IRAK-2 mRNA but lower amounts of IRAK-2C, both 
basally and upon TLR stimulation (Fig. 7 C).
Although our findings (Fig. 6 B), as well as a previous 
study (Hardy and O’Neill, 2004), demonstrate an inhibitory 
role for IRAK-2C in the TLR response, the position at 
which it interacts with the signal transduction pathway is not 
known. To address this, we examined MAPK and NF-B 
status in RAW264.7 cells ectopically overexpressing IRAK-2C. 
IRAK-2C overexpression attenuated IB degradation and 
p105 phosphorylation but exerted only a minimal effect on 
p38 MAPK activation and no effect on ERK (Fig. 7 D). 
These findings suggest that differences in IRAK-2C expres-
sion alone are sufficient to affect NF-B activation in a mac-
rophage cell line. However, the incremental effect on IB 
activation compared with the larger decrease in IL-6 produc-
tion observed in Fig. 6 B suggests that, in addition to the 
pathways  investigated  here,  other  IRAK-2C–dependent 
mechanisms of TLR signaling inhibition may also exist.
Identification of IRAK2C promoter mutations
We next asked if differences in IRAK-2C expression medi-
ated by the Why1 locus link the mechanistic observations to 
the mapping association studies. To confirm that cis-acting 
regulatory elements within the Why1 interval mediate the 
IRAK-2C expression differences between strains, we exam-JEM VOL. 206, July 6, 2009 
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Figure 7.  IRAK-2C is differentially expressed between MOLF/Ei and C57BL/6J macrophages and inhibits NF-B activity. (A) BMDMs from 
MOLF/Ei and C57BL/6J mice were stimulated for the indicated times with 2 µg/ml LTA and IRAK-2C mRNA was assessed using real-time PCR primers with 
a forward primer located within the unique 5 untranslated region of IRAK-2C and a reverse primer located within IRAK-2 exon 6. Primer specificity was 
confirmed by agarose gel electrophoresis and sequencing (not depicted). (B and C) Peritoneal macrophages from the indicated strains were stimulated for 
the times shown with 2 µg/ml LTA. IRAK-2C mRNA was quantified as in A and total IRAK-2 mRNA was quantified using primers common to all isoforms (C). 
Error bars indicate SEM. (D) RAW264.7 cells were transduced with a lentiviral construct coding for the MOLF/Ei allele of IRAK-2C. Cells were stimulated  
for the indicated times with 2 µg/ml LTA, and NF-B and MAPK pathways were assessed by Western blot analysis. Total p38 and ERK served as loading 
controls. All data are representative of two to four independent experiments.1626 CENTRAL ROLE FOR IRAK-2 IN THE MOLF/Ei TLR RESPONSE | Conner et al.
Figure 8.  Identification of cis-acting regulatory elements conferring differential IRAK-2C expression. (A) Genomic DNA or cDNA from 
F1(C57BL/6JxMOLF/Ei) macrophages was PCR amplified and analyzed by sequence analysis to determine allelic bias in IRAK-2C transcript. (B) Sequence 
alignment of the genomic region of IRAK-2C from three wild-derived strains (top three lanes) and C657BL/6J (bottom lane). Positions of the elements are JEM VOL. 206, July 6, 2009 
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IRAK-2 emerged as the likely candidate in our mapping 
studies because of the known role of IRAK family kinases in 
TLR-mediated signaling pathways. Its candidacy was further 
supported by the strain-specific effect of IRAK-2 silencing, 
which preferentially inhibited the signaling pathways that were 
hyperresponsive in MOLF/Ei and C57BL/6J-Why1 congenic 
mice. The mutation identified in the promoter of the IRAK-2C 
isoform is a 10-bp deletion covering a CACC consensus   
element that lies in the 5 untranslated region. This element has 
a predicted ability to bind Kruppel-like and Sp1 transcription 
factors (Philipsen and Suske, 1999). Together with a GATA-
specific site that is present in C57BL/6J but not MOLF/Ei 
mice and located 5 to the deletion, the CACC site is able 
to provide constitutively high as well as stimulus-dependent 
expression of IRAK-2C in C57BL/6J but not MOLF/Ei mice. 
The presence of both sites within the C57BL/6J promoter is 
especially pertinent, given previous studies on synergistic gene 
transactivation by elements binding each of these sites indepen-
dently (Merika and Orkin, 1995; Gregory et al., 1996).
The outcome of this differential expression of IRAK-2 
isoforms is a higher ratio of proinflammatory IRAK-2A rela-
tive to the inhibitory IRAK-2C in MOLF/Ei macrophages, 
which, in turn, allows IRAK-2A to assume a more central 
role in TLR activation early after stimulation (Fig. 9). Our 
model considers a critical function for IRAK-2A in MOLF/Ei 
mice, which provides additional stimulation for NF-B and 
p38-mediated signaling. In contrast, the highly expressed 
IRAK-2C isoform in classical inbred mice potentially offsets 
the  proinflammatory  effect  of  IRAK-2A  during  the  early 
phase of activation. Our data show that IRAK-2A is required 
but not sufficient for signaling in MOLF/Ei, suggesting that 
other gene products are almost certainly involved. In addi-
tion to the data presented here, our initial mapping revealed 
strong epistatic interactions between Why1 and other loci in 
the genome (Conner et al., 2008). Furthermore, there may 
be additional recessively inherited loci that promote inflam-
mation but that would only be revealed using a reciprocal 
(MOLF/Eix[MOLFEixC57BL/6J]) backcross.
Previous analysis of mice with a targeted null mutation in 
IRAK-2 revealed its role in sustained levels of NF-B–mediated 
gene activation (Kawagoe et al., 2008; Wan et al., 2009). Our 
analysis extends these findings by showing that in a wild-
derived mouse model, IRAK-2 is indispensable for the early 
response. Silencing of IRAK-2 dramatically down-regulates 
IL-6 production in these mice, bringing it to levels even lower 
than those in C57BL/6J macrophages. In addition, the mech-
anistic basis for the phenotype provides a potential explana-
tion for why targeting IRAK-2 in classical inbred strains does 
not provide an immediate effect on signaling: the balance be-
tween  pro-  and  antiinflammatory  isoforms  of  IRAK-2  in 
these strains is such that IRAK-2C may be capable of effec-
tively inhibiting IRAK-2A. As the peak of IRAK-2C mRNA 
accumulation occurs at 1.5 h after stimulation, the proinflam-
matory nature of IRAK-2A may only become apparent at 
later time points. For the same reason, we observed that 
silencing of IRAK-2 in C57BL/6J macrophages does not alter 
signaling in the first hours after activation because the proin-
flammatory isoform is checked by high levels of IRAK-2C at 
these times. This model is further supported by our findings 
that at very early time points (30 and 60 min) after TLR stim-
ulation, IRAK-2 knockdown is associated with a slight 
increase in IL-6 production in C57BL/6J mice (Fig. 5 B).
Several  negative  regulators  of  TLR-mediated  signaling 
have been described, which exert their inhibitory effect at dif-
ferent positions within the pathway. Some of these inhibitors 
are products of alternative splicing, such as MyD88s (Janssens 
et al., 2002; Burns et al., 2003), soluble TLR2 (LeBouder 
et al., 2003), and soluble TLR4 (Iwami et al., 2000); others, 
like IRAK-M, are sole gene products (Kobayashi et al., 2002). 
In this paper, we propose that the previously described inhibi-
tory molecule IRAK-2C, which originates from a unique 
promoter within the Irak2 gene, plays a role in the regulation 
of the TLR response of classical inbred mouse strains. The 
mechanism by which IRAK-2C inhibits TLR signaling re-
mains to be elucidated. However, the domain structure of 
IRAK-2 offers some important clues. The death domain, po-
sitioned at the N terminus of full-length IRAK-2 is required 
for its interaction with MyD88 (Muzio et al., 1997) and likely 
with the MyD88 like adaptor MAL (Fitzgerald et al., 2001). 
The complete absence of the death domain in IRAK-2C sug-
gests that it would not interact with these signaling compo-
nents at the membrane. In contrast, IRAK-2 is proposed to 
interact with the key cytoplasmic adaptor molecule TRAF6 
through its C terminus, leading to ubiquitination and activa-
tion of TRAF6 (Keating et al., 2007). Because the C terminus 
of IRAK-2C is identical to full-length IRAK-2, it may still 
given in base pairs with respect to the transcription initiation site (at 0 bp). Red boxes, mutations common for all wild-derived strains; Blue box, splice 
acceptor site for IRAK-2A isoforms; red text, NF-B consensus and translation start of the IRAK-2C protein. Consensus sites were identified using MatIn-
spector software (Genomatix Software GmbH). (C) EMSA was performed using nuclear extracts of LPS-activated RAW cells and a double-stranded  
32P-labeled oligonucleotide corresponding to the sequence containing the GATA-binding site. Cold competition assay was performed with 5×-, 25×-, or 
100×-fold excess of either B6 or MOLF unlabeled oligonucleotide. (D) Nuclear extracts from LPS-activated RAW cells were incubated with radiolabeled 
probe derived from C57BL/6J sequence or a sequence with an (A/T) substitution in the CACC-binding site (mutant). Alternatively, a MOLF-derived probe 
from the region corresponding to the 10-bp deletion was used. (E) RAW264.7 cells were stably transfected with constructs containing the indicated IRAK-2C 
promoter regions from MOLF/Ei or C57BL/6J fused to luciferase. Equivalent levels of transfection and integration were confirmed using real-time PCR 
analysis of genomic DNA (not depicted). Cells were stimulated with 100 ng/ml LPS for the indicated times and luciferase was quantified as a measure of 
promoter activity. Values are expressed relative to unstimulated MOLF/Ei promoter constructs and are shown as mean ± SEM of three wells. Data are rep-
resentative of three independent experiments.
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synergize with p38-dependent pathways to specifically enhance 
the transcription of IL-6.
Remarkably, IRAK-2 knockdown on a MOLF/Ei back-
ground had its largest effects on the same signaling molecules 
that were hyperresponsive relative to C57BL/6J. Further-
more, IRAK-2A and IRAK-2C overexpression in a macro-
phage cell line vastly affected IL-6 mRNA accumulation, 
whereas effects on TNF- were less substantial. These results 
imply that IRAK-2 not only amplifies the signal from TIR 
domain–containing molecules but also provides specificity 
for such amplification. Such discrimination between different 
targeted MAPKs has not yet been reported for any of the 
upstream components of the TLR-mediated pathway. This 
effect of IRAK-2 will be important to investigate further.
Although ubiquitously expressed pathogen-associated 
molecules activate a relatively small number of TLRs, the effects 
of TLR-responsive genes are quite specific. Their individual 
actions can heavily bias the remaining immune response by, 
for example, promoting the development of T effector subsets 
toward a Th1, Th2, Th17, or T reg phenotype (Iwasaki and 
Medzhitov, 2004). In considering the effect of the early innate 
immune  system  on  subsequent  processes,  the  evolutionary 
context under which wild-derived mice have recently existed 
is critical. It is remarkable that incorporation of such TLR-
proximal factors as IRAK-2 has arisen to shape differential 
expression of specific cytokine genes.
Whereas the MOLF/Ei allele of Why2 was associated with 
an inhibitory effect on TLR-induced IL-6 production (Conner 
et al., 2008), the findings reported in this paper show that 
interact with TRAF6 and potentially sequester this molecule 
away from IRAK-2A and other critical membrane signaling 
components. Our results demonstrate that knockdown of all 
IRAK-2 isoforms in the low IRAK-2C–expressing MOLF/Ei 
strain has an overall inhibitory effect, whereas no major   
effect is seen in the high IRAK-2C–expressing C57BL/6J 
strain. These findings suggest that direct inhibition of IRAK-2A 
will be an essential aspect IRAK-2C’s mechanism.
One of the most surprising findings that emerged from 
our studies of the TLR response in MOLF/Ei mice was the 
observed  specificity  in  affected  early  upstream  signaling 
mediators. In addition to activation of the NF-B pathway, 
MOLF/Ei mice displayed specific hyperactivity in p38, but 
not ERK or JNK, MAPK phosphorylation. These data are 
consistent with our observation that not all cytokines are in-
creased in MOLF/Ei TLR responses relative to classical in-
bred mouse strains. The largest effect was observed for IL-6 
mRNA produced at early time points after stimulation. 
C57BL/6J and MOLF/Ei macrophages displayed similar levels 
of TNF- and IL-12p40 transcription, which, like IL-6 are 
known to be NF-B–dependent genes (Shakhov et al., 1990; 
Sanjabi  et  al.,  2005).  The  underlying  mechanism  for  this 
specificity remains incompletely characterized. p38 has been 
shown to play a critical role in IL-6 transcription through 
histone H3 phosphorylation (Saccani et al., 2002), as well as 
through activation of the transcription factor CREB, whereas 
it has a smaller effect on TNF- and IL-12p40 transcription 
(Park et al., 2005). Other signaling mediators may also be 
hyperresponsive in MOLF/Ei macrophages, which could 
Figure 9.  Model of IRAK-2 usage in MOLF/Ei compared with C57BL/6J TLR signal transduction. In MOLF/Ei macrophages, knockdown experi-
ments reveal that IRAK-2 plays a central role in activation of p38 and IKK, two pathways which show increased activity relative to C57BL/6J mice. Neither 
of these phenotypes can be completely recapitulated with the MOLF/Ei allele on a classical inbred background, suggesting that additional MOLF/Ei alleles 
are important for the complete levels of hyperresponsiveness observed in comparing parental strains. The MOLF/Ei allele of Irak2 expresses less of the 
IRAK-2C isoform, which may underlie the phenotype by decreasing interference with IRAK-2A activity. In C57BL/6J macrophages, which express an in-
creased amount of IRAK-2C, previous studies have demonstrated that early TLR signaling events are not controlled by IRAK-2, although it is important for 
late activation of the NF-B axis.JEM VOL. 206, July 6, 2009 
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MOLF/Ei Why1 promotes a faster and more robust IL-6 re-
sponse. The coevolution of these two opposing loci may have 
been critical, allowing ancestral wild-derived species to de-
velop uniquely potent yet, at the same time, highly regulated 
innate immune functions. Previous studies have described 
both increased susceptibility and resistance of wild-derived 
strains in various infectious models (Urosevic et al., 1999; 
Sebastiani et al., 2002). Although neither of these phenotypes 
has been genetically mapped to the Why1 or Why2 loci from 
our studies, the unique cytokine response profile that we ob-
serve in vitro will likely have corresponding outcomes in the 
context of a live infection. Under the circumstances of persis-
tent pathogen replication and the formation of an adaptive 
response, the Why1 and Why2 loci may help to identify im-
portant effects of the time course and specificity of cytokines 
produced by the innate immune system on the development 
of infectious or host mediated pathology.
The scientific approach of studying individual genes in 
isolation is increasingly giving way to the appreciation of net-
worked genes working together to determine complex phe-
notypes (Oda and Kitano, 2006). Wild-derived mice are ideal 
models for comparison of different gene networks. Our data 
so far support the hypothesis that innate immune networks in 
classical and wild-derived inbred mice are organized differ-
ently and will be rich in unique gene–gene interactions. In 
addition to identifying single components of these interac-
tions (which could themselves be novel), the biggest potential 
of this work is the ability to establish new signaling pathways, 
which would otherwise be difficult to predict. Our data dem-
onstrate that IRAK-2A is positioned in the center of the 
TLR scaffold in MOLF/Ei and that it is likely much less 
affected by the inhibitory isoform IRAK-2C. Interestingly, 
there is only one proinflammatory human homologue of 
IRAK-2, which suggests a greater similarity between organi-
zation of TLR signaling elements in humans and wild-derived 
mice compared with classically used strains. This possibility 
strongly supports further characterization of immunological 
responses in wild-derived mice for their potential to model 
critical elements of human biology.
MaTerials and MeTHods
Mice and isolation of MEFs. C57BL/6J and MOLF/Ei parental strains 
were obtained from The Jackson Laboratory. All mice were housed in a 
pathogen-free facility at the Tufts University School of Medicine. MEFs 
were isolated from 13.5-d mouse embryos by trypsination after removal of 
the head and liver. All mouse procedures were performed under a protocol 
approved by the Tufts University/Tufts Medical Center Institutional Animal 
Care and Use Committee.
Cells. Primary cells were harvested for phenotypic analysis from all mice at 
6–10 wk of age. Peritoneal macrophages were obtained by injection with 1 ml 
of 3% thioglycollate. 3 d after priming, the peritoneal cavity was washed 
with cold PBS and cells were suspended in DMEM, 10% FBS (Atlanta Bio-
logicals), and 1% Pen-Strep (Invitrogen). Cells were plated and incubated 
overnight at 37°C in 5% CO2 before phenotypic analysis. BMDMs were 
matured and maintained as previously described (Conner et al., 2008). The 
RAW264.7 mouse macrophage cell line (American Type Culture Collec-
tion) was grown in DMEM, 10% FBS, and 1% Pen-Step.
Reagents. CpG, loxoribine, and purified LTA from Staphylococcus aureus 
(tlrl-pslta) were obtained from InvivoGen. Salmonella Minnesota Re595 
LPS was obtained from Enzo Biochem., Inc. Poly I:C was obtained from GE 
Healthcare. Rabbit polyclonal antibodies to phosphorylated and total p38, 
ERK, and JNK, as well as phosphorylated IKK-/ and p105, were ob-
tained from Cell Signaling Technology. Polyclonal antibodies to IRAK-1, 
IB, and IB were obtained from Santa Cruz Biotechnology, Inc.
TLR stimulation and phenotypic assays. All cells were plated and incu-
bated overnight before stimulation. For ELISA analysis, 200,000 cells were 
plated per well in a 48-well tissue culture-treated dish. Cells were stimulated 
with prewarmed media containing the TLR agonist for 6 h, after which super-
natants were harvested. IL-6 was measured using anti–mouse Duo-Set IL-6 
ELISA (DY-406; R&D Systems). For mRNA analysis, cells were plated at a 
density of 700,000 per well in a 12-well dish. After stimulation, cells were 
lysed using TRIZOL (Invitrogen). Complementary DNA (cDNA) was syn-
thesized using random primers and Mu-MLV reverse transcription (New 
England Biolabs, Inc.), followed by real-time PCR analysis using mouse IL-6 
or TNF- along with GAPDH Taqman probes (Applied Biosystems).
Western blot analysis. After TLR stimulation, cells were lysed on ice with 
a cytoplasmic lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 2 mM EDTA, 
1% Triton X-100, 1 mM NaVanadate, and 10 mM NaF) supplemented 
with Halt protease inhibitor cocktail (Thermo Fisher Scientific) for 10 min. 
Lysates were then centrifuged at 13,000 rpm at 4°C for 10 min. Cleared lysates 
were resolved on a 4–12% gradient Bis-Tris SDS gel (NuPAGE; Invitrogen) 
and transferred to a nitrocellulose membrane. After incubation with specific 
antibodies, chemiluminescence was detected using ECL substrate (Thermo 
Fisher Scientific).
Lentiviral  transduction.  IRAK-2  targeting  shRNA  constructs  in   
the pLKO.1 vector were obtained from Open Biosystems (Constructs 1, 2, 
and 3 represent clone IDs TRCN000022499, TRCN000022502, and 
TRCN000022503, respectively). IRAK-2A and IRAK-2C cDNAs were 
cloned using PCR from C57BL/6J or MOLF/Ei cDNA into the pLEX 
(Open Biosystems) lentiviral expression vector for ectopic expression experi-
ments. Lentiviral particles were generated by transfection (FuGENE) of the 
expression construct into 293-T cells along with the packaging constructs 
pSPAX2 and pMD2.G (Addgene). Supernatant from 293-T cells was har-
vested on days 2 and 3 after transfection and was 0.45-µm filtered. All cells 
were infected by incubation with a 1:1 ratio of viral supernatant for 24 h. 
BMDMs were infected on day 4 of maturation and selected with 3 µg/ml 
puromycin beginning on day 6. Peritoneal macrophages were infected im-
mediately upon plating for 24 h and recovered for 48 h with no selection 
before assays were performed. RAW264.7 macrophages were infected for 24 h, 
recovered for 24 h, and subsequently selected in 3 µg/ml puromycin.
IRAK-2 mRNA quantification. For quantification of IRAK-2 isoforms, 
real-time PCR primers were designed to amplify all isoforms or IRAK-2C 
specifically by using a forward primer in the 4 exon, which has been previ-
ously described as unique to IRAK-2C (Hardy and O’Neill, 2004). Specific-
ity of primers was assessed using agarose gel electrophoresis and sequencing 
of the products. Cells were stimulated and cDNA was prepared as de-
scribed in TLR stimulation and phenotypic assays, followed by amplifica-
tion with SYBR Green (Applied Biosystems). All cells were normalized with 
a GAPDH-specific primer set.
DNA  sequencing.  After  PCR  amplification  from  genomic  DNA  or 
cDNA, products were isolated on an agarose gel and extracted (QIAGEN). 
DNA was sequenced at the Tufts University Core Facility using a 3130XL 
sequencer (Applied Biosystems).
EMSA. RAW264.7 cells were left untreated or stimulated with 100 ng/ml 
of LPS in DMEM for 1 h, after which nuclear proteins were extracted   
using  NucBuster  (EMD)  and  incubated  with  Klenow-labeled  double-1630 CENTRAL ROLE FOR IRAK-2 IN THE MOLF/Ei TLR RESPONSE | Conner et al.
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